NuWays Reaffirms Buy on DEMIRE With EUR 0.70 Price Target
Bitget2026/11/06 08:01- NuWays reiterated Buy on DEMIRE in its November 6, 2026, report, setting a 12-month price target of EUR 0.70.
- Third-quarter rental income fell 20.2% to EUR 10.9 million; FFO I of EUR 800,000 exceeded the research firm's estimate.
- Disposals lifted cash to EUR 82.6 million, but roughly 40% sits within Fair Value REIT.
- NuWays identified refinancing EUR 251 million of 2019/2027 notes maturing at end-2027 as the key near-term risk.
- Apollo and Wecken's proposed sale of their approximately 91% stake remains pivotal; a change of control could trigger the notes' 101% put.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.
Crypto prices
More
